---
layout: post
title: 'Reactivation of Hepatitis B Virus After Treatment with Direct Acting Antivirals for Hepatitis C: What You Need To Know'
date: 2017-01-21 10:00:00
---

[![](/assets/images/reactivation-of-hepatitis-b-virus-after-treatment-with-direct-acting-antivirals-for-hepatitis-c-what-you-need-to-know.png)](https://www.hhs.gov/hepatitis/blog/2017/1/17/hbv-reactivation-during-hcv-treatment.html)

**Summary:**

Offers a description of HBV reactivation that can occur alongside DAA treatment for HCV; discusses the new FDA black box warning for individuals starting DAA treatment for HCV; provide action steps for both patients and providers, in order to help prevent HBV reactivation and the negative health outcomes associated with it.

[**>> Go to HHSBlog**](https://www.hhs.gov/hepatitis/blog/2017/1/17/hbv-reactivation-during-hcv-treatment.html)

